Tissue distribution of molidone in a multidrug overdose

Journal of Analytical Toxicology

Volumn 28, Issue 6, 2004, Pages 533-536

  Flammia, Dwight D ^a   Bateman, Henry R ^a   Saady, Joseph J ^a,c   Christensen, Erik D ^b  

^a Virginia Division of Forensic Science   (United States)

^b Greenville County Medical Examiner's Office   (United States)

^c Joint Requirements Office   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BUTYROPHENONE DERIVATIVE; DIBENZEPIN; HEXANE; ISOPENTYL ALCOHOL; LITHIUM; MOLINDONE; NEUROLEPTIC AGENT; NITROGEN; PHENOTHIAZINE DERIVATIVE; PHOSPHORUS; SOLVENT; SULFURIC ACID; THIOXANTHENE DERIVATIVE; TOLUENE;

ADULT; ATOMIC ABSORPTION SPECTROMETRY; AUTOPSY; CASE REPORT; CAUSE OF DEATH; CONFERENCE PAPER; DRUG BILE LEVEL; DRUG BLOOD LEVEL; DRUG LIVER LEVEL; DRUG OVERDOSE; DRUG URINE LEVEL; FEMALE; GAS CHROMATOGRAPHY; HUMAN; MASS SPECTROMETRY; QUANTITATIVE ANALYSIS; SCHIZOPHRENIA; TISSUE DISTRIBUTION;

EID: 4344574873     PISSN: 01464760     EISSN: None     Source Type: Journal    
DOI: 10.1093/jat/28.6.533     Document Type: Conference Paper

References (19)

1. F.S. Abuzzahab, Sr. Treatment of acute schizophrenia with molindone. J. Clin. Pharmacol. 13: 226-233 (1973).
2. R.R Owen, Jr. and J.O. Cole. Molindone hydrochloride: a review of laboratory and clinical findings. J. Clin. Psychopharmacol. 9: 268-276(1989).
3. A. Rubin, H.C. Yen, and M. Pfeffer. Psychopharmacological profile of molindone. Nafure 216: 578-579 (1967).
4. Moban® (molindone hydrochloride). In Physicians' Desk Reference 56th ed. Medical Economics Company, Montvale, NJ, 2002, pp 1320-1321.
5. A.K. Pandurangi and N. Narasimhachari. Rhabdomyolysis and molindone. J. Clin. Psychiatry 49: 37 (1988).
6. M.E. Wolf and A.D. Nosnaim. Lithium and molindone interactions: pharmacokinetic studies. Res. Commun. Psychol. Psych. Behav. 11:23-28 (1986).
7. A.A. Sugerman and J. Herrmann. Molindone: an indole derivative with antipsychotic activity. Clin. Pharm. Ther. 8: 261-265 (1966).
8. R. Kellner, R.T. Rada, A. Egelman, and B. Macaluso. Long-term study of molindone hydrochloride in chronic schizophrenics. Curr. Ther. Res. Clin. Exp. 20: 686-694 (1976).
9. R. Binder, I. Click, and M. Rice. A comparative study of parenteral molindone and haloperidol in the acutely psychotic patient. J. Clin. Psychiatry 42: 203-206 (1981).
10. F. Fernandez and J.K. Levy. The use of molindone in the treatment of psychotic and delirious patients infected with the human immunodeficiency virus. Gen. Hosp. Psychiatry 15: 31-35 (1993).
11. P. Seeman and T. Tallerico. Antipsychotic drugs which elicit little or no parkinsonism bind more loosely than dopamine to brain D2 receptors, yet occupy high levels of these receptors. Mol. Psychiatry 3:123-134 (1998).
12. J. Shelton, J.J. Prusmack, and L.E. Hollister. Molindone, a new type of antipsychotic drug. J. Clin. Pharmacol. J. New Drugs 8: 190-195 (1968).
13. C.E. Wesp, Jr., W. Annitto, and R. Feinsod. Galactorrhea associated with molindone. Clin. Res. Reports 136:975 (1979).
14. S.E. Katz. Tardive dyskinesia associated with molindone treatment. Am. J. Psychiatry 147: 124-125 (1990).
15. L. Glickman. Rhabdomyolysis and acute renal failure. J. Clin. Psychiatry 48: 299 (1987).
16. J.D. Gradon. Neuroleptic malignant syndrome possibly caused by molindone hydrochloride. DICP Ann. Pharmacother. 25: 1071-1072 (1991).
17. L.E. Hollister. Some human pharmacological studies of three psychotropic drugs: thiothixine, molindone, and w-1867. J. Clin. Pharmacol. 8: 95-101 (1968).
18. R.C. Baselt. Disposition of Drugs and Chemicals in Man, 6th ed. Biomedical Publications, Foster City, CA 2002, p 718.
19. M.G. Mallinckrodt, G. Jacob, and K.H. Scaller. Lithium distribution in body fluids and organs after treatment with quilonum retard (r) (lithium carbonate). Vet. Hum. Toxicol. 21:187-190 (1979).